Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07630844 · ClinicalTrials.gov registry record · NA
REFRAME: an Emotion Regulation Intervention to Improve Psychological Outcomes in Surrogate Decision-Makers of the Critically Ill
A NA study, sponsored by Case Western Reserve University.
- Not yet
- Registry status
- NA
- Development phase
- 387
- Enrollment target
NCT07630844: Clinical Trial NA study, sponsored by Case Western Reserve University.
NCT07630844 is a NA study that has not yet begun recruiting, run by Case Western Reserve University. The registered enrollment target is 387 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07630844, a NA study, has not yet begun recruiting, sponsored by Case Western Reserve University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 387 participants
- Enrollment target
Study Summary
Every year in the United States, millions of adults make crucial medical decisions for loved ones in the intensive care unit while facing extreme emotional stress. This project will assess REFRAME, a brief tablet-based program designed to help decision-makers manage their emotions in these situations. Results from this study may lead to the creation of a widely accessible tool that alleviates emotional suffering and enhances the quality of medical decision-making for families in crisis.
Primary Outcome
PROMIS Depression is an eight-item scale with items scored on a five-point Likert scale ranging from 1 (Never) to 5 (Always). Items are summed with higher scores indicating greater depressive symptoms.
Interventions
- BEHAVIORAL Informational Support
- BEHAVIORAL REFRAME
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 387 participants |
| Start Date | 2027-01-04 |
| Est. Completion | 2031-04-04 |
| Phase | NA |
What is known before NCT07630844 opens enrollment
NCT07630844 is an interventional study that assigns participants to a tested intervention. The registered 387 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower).
The record links to 0 conditions, and to 2 interventions - of which Informational Support is the first listed.
NCT07630844 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07630844 about?
NCT07630844 is a clinical study titled "REFRAME: an Emotion Regulation Intervention to Improve Psychological Outcomes in Surrogate Decision-Makers of the Critically Ill". Every year in the United States, millions of adults make crucial medical decisions for loved ones in the intensive care unit while facing extreme emotional stress. This project will assess REFRAME, a brief tablet-based program designed to help decision-makers manage their emotions in these situation...
What is the current status of trial NCT07630844?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 387 participants. The study started on 2027-01-04. Estimated completion is 2031-04-04.
What interventions are being tested in trial NCT07630844?
The interventions under investigation include: Informational Support (BEHAVIORAL), REFRAME (BEHAVIORAL).
Who is sponsoring clinical trial NCT07630844?
This trial is sponsored by Case Western Reserve University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07630844's enrollment target sits among peer trials
387 271st of 2000 higher than 1,730 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03761108 · 387 participants · Phase 1
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma
- NCT05572632 · 387 participants · NA
Rehabilitation in Safety-net Environments (RISE) to Improve Outcomes in Vulnerable Patients With COPD
- NCT06917079 · 387 participants · Phase 1
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
- NCT04092010 · 388 participants · NA
Improving Preschool Outcomes by Addressing Maternal Depression in Head Start
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI